Danaher | DHR - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.65B 787M 2026-06
Agilent USD 990M 44M 2026-03
Align Technology USD 757.43M 20.84M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Bio Techne USD 208.29M 17.01M 2026-03
Bio-Rad Laboratories USD 345.8M 36.4M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Bruker USD 416M 36.2M 2026-06
Charles River Laboratories USD 348.78M 69.47M 2026-06
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 493M 66M 2026-06
Edwards Lifesciences USD 1.35B 62.6M 2026-06
ESCO Technologies USD 121.18M 10.14M 2026-06
Fortive USD 695.3M 19.8M 2026-06
Henry Schein USD 1.03B 39M 2026-06
Illumina USD 770M 49M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Keysight Technologies USD 1.18B 183M 2026-03
Laboratory Of America USD 1.11B 98.2M 2026-06
Medtronic USD 6.01B 595M 2026-03
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Quidel USD 223.9M 315.7M 2026-06
Repligen USD 110.04M 1.75M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Roper Industries USD 1.45B 23.9M 2026-03
Stryker USD 4.5B 688M 2026-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 490M 52M 2026-06
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06